Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2024 / Jun / Also in the News…
Research & Innovations Anterior Segment Cornea Glaucoma Pediatric

Also in the News…

From business acquisitions to UK firsts to the importance of physical exercise in reducing senile cataract risks, these are the studies that caught our attention this week…

By Alun Evans 6/7/2024 3 min read

Share

Headshot supplied by Thomas Poole

From business acquisitions to UK firsts to the importance of physical exercise in reducing senile cataract risks, these are the studies that caught our attention this week…

EyeBio acquisition. Jeito Capital recently announced that its portfolio company, EyeBio, has been acquired by the pharmaceutical company, Merck & Co. EyeBio is the company behind the development of Restoret, the Wnt signaling pathway agonist that is due to enter a pivotal study for diabetic macular edema in the second half of 2024. Link

England’s first cornea transplant. Surgeons have performed the first artificial cornea transplant in England. The endothelial keratoplasty was undertaken by consultant ophthalmologist Thomas Poole and his colleague Hanbin Lee at Frimley Park Hospital, Camberley, Surrey. Link

New DED product. Bausch + Lomb has announced the launch of Blink NutriTears. The over-the-counter supplement – consisting of Vitamin D, curcumin, lutein, and zeaxanthin – is designed to target dry eye disease (DED) and has been shown to provide statistically significant relief for DED symptoms, according to the company. Link

Corneal edema risk. A person’s race (particularly if they are Hispanic, Asian, and North American native), their age, and whether or not they have diabetes all contribute towards a higher risk of post-cataract corneal edema (CE), according to an American Journal of Ophthalmology study. The authors recommend that further research be undertaken to better understand why CE disproportionately affects racial and ethnic minorities in the US. Link

No Fluoroquinolone link. Fluoroquinolone – the antibiotic treatment often used for genitourinary infections – causes no substantial increase in either retinal detachment or uveitis, according to a new JAMA Ophthalmology study. Though an association between the treatment and these risks cannot be completely ruled out, the findings – based on an extensive cohort of nearly 3.5m adults who were prescribed either fluoroquinolone or comparator antibiotic, cephalosporin, between 1997 and 2019 – suggest that the potential risk was of limited clinical importance. Link

Cataracts and keeping fit. Examining data obtained from the UK Biobank cohort – consisting of medical information from 400,000 individuals aged 40-69 – researchers from Wenzhou Medical University, China, found that moderate-to-vigorous physical activity can reduce the risks of senile cataracts, highlighting the importance of preventative health strategies for at-risk patients. Link

About the Author(s)

Alun Evans

More Articles by Alun Evans

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: